Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
Daiichi Sankyo reports solid launch for touted ADC Datroway
Daiichi Sankyo and AstraZeneca's TROP2-directed ADC Datroway is off to a "smooth market launch,” according to Daiichi CEO Hiroyuki Okuzawa.
Kevin Dunleavy
Apr 28, 2025 5:00pm
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
Enhertu drives strong efficacy in first-line breast cancer
Apr 21, 2025 10:12am
Trump policy, Pfizer, CMIC—Fierce Pharma Asia
Mar 7, 2025 8:05am
AZ, Daiichi's Enhertu delivers survival win in stomach cancer
Mar 3, 2025 3:43pm
AstraZeneca logs China sales decline in Q4 amid probes
Feb 6, 2025 10:31am
